Provided By Globe Newswire
Last update: Jun 22, 2022
- These results are the first reported demonstration of rapid and robust treatment changes in key disease markers associated with the severity of disease
- Initial pharmacodynamic results for two participants show unprecedented decreases in N-acetylaspartate (NAA) in the brain and urine, suggesting the therapy is producing functional ASPA enzyme
Read more at globenewswire.com